Inovelon oral suspension available to prescribe

Eisai has launched a liquid version of the antiepileptic, Inovelon (rufinamide).

Rufinamide is contraindicated in patients who have had a previous hypersensitivity reaction to triazole derivatives
Rufinamide is contraindicated in patients who have had a previous hypersensitivity reaction to triazole derivatives

Inovelon (rufinamide) 40mg/ml oral suspension is licensed as an adjunct in the treatment of Lennox-Gastaut syndrome in patients 4 years of age and older.

Dose is determined by the patient’s weight and concomitant use of valproate. The suspension can be interchanged at equal doses with the tablets.

View Inovelon Oral Suspension drug record

Further information: Eisai Ltd

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.

Ranitidine in short supply after contamination fears prompt precautionary recall

Ranitidine in short supply after contamination fears prompt precautionary recall

GPs have reported shortages of ranitidine following...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Alzhok and ranitidine oral soln.
Use our...

Excessive steroid dosing highlighted in inflammatory bowel disease

Excessive steroid dosing highlighted in inflammatory bowel disease

Some patients with Crohn's disease or ulcerative colitis...